MOSS — Moss Genomics Income Statement
0.000.00%
Last trade - 00:00
- CA$0.90m
- CA$0.87m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 0.011 | 0.001 | 0.108 | 0.655 | 0.73 |
Operating Profit | -0.011 | -0.001 | -0.108 | -0.655 | -0.73 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.011 | -0.001 | -0.108 | -0.655 | -0.73 |
Net Income After Taxes | -0.011 | -0.001 | -0.108 | -0.655 | -0.73 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.011 | -0.001 | -0.108 | -0.655 | -0.73 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.011 | -0.001 | -0.108 | -0.655 | -0.73 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0 | -0.002 | -0.015 | -0.016 |
Dividends per Share |